[Pathomechanism of Graves' disease and the effectiveness of its treatment with propranolol. II. Effect of intravenous administration of propranolol on the reverse triiodothyronine level].
D000293:Adolescent; D000328:Adult; D005260:Female; D006111:Graves Disease / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000008:administration & dosage*; D014284:Triiodothyronine / Q000097:blood*; D014285:Triiodothyronine, Reverse / Q000097:blood*
D014284:Triiodothyronine; D014285:Triiodothyronine, Reverse; D011433:Propranolol
Badania nad patomechanizmem i skutecznościa leczenia propranololem w chorobie Graves-Basedowa. Cześć II. Wpływ propranololu podawanego dozylnie na poziom revers trójjodotyroniny.